Atrial fibrillation and stroke: a practical guide

Pract Neurol. 2019 Jun;19(3):208-224. doi: 10.1136/practneurol-2018-002089. Epub 2019 Mar 2.

Abstract

Neurologists and stroke physicians will be familiar with atrial fibrillation as a major cause of ischaemic stroke, and the role of anticoagulation in preventing cardioembolic stroke. However, making decisions about anticoagulation for individual patients remains a difficult area of clinical practice, balancing the serious risk of ischaemic stroke against that of major bleeding, particularly intracranial haemorrhage. Atrial fibrillation management requires interdisciplinary collaboration with colleagues in cardiology and haematology. Recent advances, especially the now-widespread availability of direct oral anticoagulants, have brought opportunities to improve stroke care while posing new challenges. This article gives an overview of the contemporary diagnosis and management of atrial fibrillation, and the associated evidence base. Where there is uncertainty, we describe our own approach to these areas, while highlighting ongoing research that will likely guide future practice.

Keywords: stroke.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Humans
  • Intracranial Hemorrhages / complications
  • Intracranial Hemorrhages / diagnosis
  • Intracranial Hemorrhages / drug therapy
  • Risk
  • Stroke / diagnosis
  • Stroke / drug therapy*

Substances

  • Anticoagulants